-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Benitec Biopharma Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q1 2024.
- Benitec Biopharma Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2024 was -$138K, a 146% decline year-over-year.
- Benitec Biopharma Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2024 was -$200K, a 71.4% increase year-over-year.
- Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2023 was -$481K, a 35.9% decline from 2022.
- Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2022 was -$354K, a 23.8% decline from 2021.
- Benitec Biopharma Inc. annual Nonoperating Income (Expense) for 2021 was -$286K, a 4186% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)